Shane Humphries, | |
166 County Road 3915, Arley, AL 35541-2174 | |
(205) 275-2931 | |
Not Available |
Full Name | Shane Humphries |
---|---|
Gender | Male |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 166 County Road 3915, Arley, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780118091 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 1633327 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shane Humphries, 166 County Road 3915, Arley, AL 35541-2174 Ph: () - | Shane Humphries, 166 County Road 3915, Arley, AL 35541-2174 Ph: (205) 275-2931 |
News Archive
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
Aspect Imaging, the world leading developer of compact high-performance magnets, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's M2 compact MRI system for diagnostic imaging of the wrist.
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections.
› Verified 9 days ago